- 英文名称Fluprednidene Acetate
- 中文名称9-氟-11β,17,21-三羟基-16-亚甲基孕甾-1,4-二烯-3,20-二酮 21-乙酸酯
- IUPAC名称[2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-16-methylidene-3-oxo-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
- 其它别名Pregna-1,4-diene-3,20-dione,9-fluoro-11b,17,21-trihydroxy-16-methylene-,21-acetate (6CI,7CI,8CI); 9-Fluoro-16-methyleneprednisolone-21-acetate; 9a-Fluoro-16-methyleneprednisolone21-acetate; 9a-Fluprednylidene21-acetate; Corticoderm; Decoderm; Emecort; Etacortin; Fluprednidene acetate; Fluprednylidene 21-acetate; Fluprednylidene acetate
- CAS编号1255-35-2
- EINECS号:215-013-9
- FDA UNII编号:GE65DV564S
- 分子式:C24H29FO6分子量:432.4818632
- 产品CID: 379446
- 产品分类有机原料 → 脂质和类脂质分子 → 类固醇和类固醇衍生物
- 相似结构搜索
- InChIKey: DEFOZIFYUBUHHU-CODDRGOBSA-N
- InChI=1S/C24H29FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,17-19,28,30H,1,5-6,9,11-12H2,2-4H3/t17-,18-,19
- 计算化学: 氢键受体数7.0氢键供体数2.0可旋转键数4.0
欧盟法规
ECHA物质C&L通报REACH预注册海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2905122000-异丙醇
2905143000-叔丁醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-12391691-B2
优先权日:2018-11-16
标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
权利人:AMGEN INC
摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as
专利号:US-2025206736-A1
优先权日:2019-11-14
标题 :Synthesis of kras g12c inhibitor compound
发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
权利人:AMGEN INC
摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.
专利号:US-9051302-B2
优先权日:2008-01-15
标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.
专利号:US-2023192682-A1
优先权日:2019-11-14
标题:Improved synthesis of kras g12c inhibitor compound
专利号:US-2023192681-A1
优先权日:2019-11-14
标 题 :Improved synthesis of kras g12c inhibitor compound
专利号:KR-20230058630-A
优先权日:2020-07-28
标题 :Chiral synthesis of fused bicyclic RAF inhibitors